Folitrax 25MG Injection (1ml) is a pharmaceutical preparation containing Methotrexate, a potent antimetabolite and immunosuppressant agent. This medication is primarily used in the treatment of various conditions, including certain types of cancer, autoimmune diseases, and ectopic pregnancies. Methotrexate works by inhibiting the metabolism of folic acid, which is essential for DNA synthesis and cell division. The injection form allows for rapid absorption and effectiveness, making it suitable for patients who may have difficulty with oral medications. Folitrax is often administered under the supervision of a healthcare professional, ensuring that patients receive the correct dosage tailored to their specific medical needs. The composition of Folitrax includes Methotrexate at a concentration of 25mg per 1ml, along with other excipients that facilitate its delivery and stability. This drug is a critical component in modern therapeutic regimens, providing significant benefits in managing complex health conditions.

Folitrax 25MG Tablet (4’s) is a medication that contains Methotrexate, a potent antimetabolite and immunosuppressant used primarily in the treatment of various autoimmune diseases and certain types of cancer. Each tablet contains 25 mg of Methotrexate, which works by inhibiting the metabolism of folic acid, thereby interfering with DNA synthesis and cell replication. This mechanism makes Folitrax effective in managing conditions such as rheumatoid arthritis, psoriasis, and certain malignancies like leukemia and lymphoma. The drug is typically prescribed as part of a comprehensive treatment plan, and its use is closely monitored by healthcare professionals to ensure safety and efficacy. Patients taking Folitrax should be aware of its potential side effects and the importance of adhering to prescribed dosages to achieve optimal therapeutic outcomes.